11 January 2013
Researchers are developing new insights into how a HIV vaccine works could lead to a more effective way of fighting the condition, according to a new study.
Through an examination of the structure of antibody-virus complexes that are generated in vaccine recipients, it was shown how the immune system can be "triggered" to tackle the infection.
"This is the first comprehensive study of the repertoire of antibodies that were induced by an HIV vaccine and were associated with decreased transmission of HIV," explained the senior author of the study senior study author Barton Haynes from Duke University Medical Center.
"Ultimately, the motivation of the study is to understand how that vaccine works in order to develop ways to make it better."
It is the intention of the team to develop an even more effective vaccine than the ones currently available. Around the world over 34 million people live with HIV, which can develop into AIDS, nowadays known as late-stage HIV-infection.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.